OTCMKTS:INVVY - INDIVIOR PLC/S Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding INDIVIOR PLC/S Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $2.85 -0.13 (-4.36 %) (As of 02/16/2020 04:00 PM ET) Add Today's Range$2.65Now: $2.85▼$3.1050-Day Range$2.30MA: $2.59▼$3.3052-Week Range$1.98Now: $2.85▼$7.74Volume92,841 shsAverage VolumeN/AMarket CapitalizationN/AP/E Ratio2.48Dividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence. The company's product pipeline focuses on treating opioid use disorder, alcohol use disorder, opiate overdose, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy analgesic products that include Temgesic, Burpex, and Buprenex. Read More… Industry, Sector and Symbol Stock Exchange OTCMKTS Industry N/A Sub-IndustryN/A SectorN/A Current SymbolOTCMKTS:INVVY Previous SymbolNASDAQ:INVVY CUSIPN/A CIKN/A WebN/A PhoneN/ADebt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E Ratio2.48 Forward P/E Ratio6.63 P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees915 Outstanding SharesN/AMarket CapN/A Next Earnings Date5/7/2020 (Estimated) OptionableNot Optionable Receive INVVY News and Ratings via Email Sign-up to receive the latest news and ratings for INVVY and its competitors with MarketBeat's FREE daily newsletter. OTC:INVVY Rates by TradingView INDIVIOR PLC/S (OTCMKTS:INVVY) Frequently Asked Questions What is INDIVIOR PLC/S's stock symbol? INDIVIOR PLC/S trades on the OTCMKTS under the ticker symbol "INVVY." How were INDIVIOR PLC/S's earnings last quarter? INDIVIOR PLC/S (OTCMKTS:INVVY) issued its quarterly earnings results on Thursday, February, 13th. The company reported ($0.25) earnings per share for the quarter. The firm earned $133 million during the quarter. View INDIVIOR PLC/S's Earnings History. When is INDIVIOR PLC/S's next earnings date? INDIVIOR PLC/S is scheduled to release their next quarterly earnings announcement on Thursday, May 7th 2020. View Earnings Estimates for INDIVIOR PLC/S. What guidance has INDIVIOR PLC/S issued on next quarter's earnings? INDIVIOR PLC/S updated its FY 2020 Pre-Market earnings guidance on Thursday, February, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $525-585 million. Has INDIVIOR PLC/S been receiving favorable news coverage? Media stories about INVVY stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. INDIVIOR PLC/S earned a news impact score of 2.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for INDIVIOR PLC/S. What other stocks do shareholders of INDIVIOR PLC/S own? Based on aggregate information from My MarketBeat watchlists, some companies that other INDIVIOR PLC/S investors own include Indivior (INDV), Nabriva Therapeutics (NBRV), vTv Therapeutics (VTVT), Vaxart (VXRT), Armata Pharmaceuticals (ARMP), Aduro BioTech (ADRO), Agile Therapeutics (AGRX), Aytu Bioscience (AYTU), Crispr Therapeutics (CRSP) and Inovio Pharmaceuticals (INO). Who are INDIVIOR PLC/S's key executives? INDIVIOR PLC/S's management team includes the folowing people: Mr. Shaun Thaxter, CEO & Exec. DirectorMr. Mark Crossley, CFO & Exec. DirectorDr. Christian Heidbreder, Chief Scientific OfficerMr. Ingo Elfering, Chief Information & Innovation OfficerMr. Jason Thompson, VP of Investor Relations How do I buy shares of INDIVIOR PLC/S? Shares of INVVY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is INDIVIOR PLC/S's stock price today? One share of INVVY stock can currently be purchased for approximately $2.85. MarketBeat Community Rating for INDIVIOR PLC/S (OTCMKTS INVVY)Community Ranking: 1.9 out of 5 ()Outperform Votes: 112 (Vote Outperform)Underperform Votes: 181 (Vote Underperform)Total Votes: 293MarketBeat's community ratings are surveys of what our community members think about INDIVIOR PLC/S and other stocks. Vote "Outperform" if you believe INVVY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INVVY will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/16/2020 by MarketBeat.com StaffFeatured Article: Do You Need a Fiduciary?
